Heron Therapeutics Ownership | Who Owns Heron Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Heron Therapeutics Ownership Summary


Heron Therapeutics is owned by 93.94% institutional investors, 0.88% insiders, and 5.18% retail investors. Rubric capital management lp is the largest institutional shareholder, holding 18.02% of HRTX shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.07% of its assets in Heron Therapeutics shares.

HRTX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockHeron Therapeutics93.94%0.88%5.18%
SectorHealthcare Stocks 35.49%11.78%52.72%
IndustryBiotech Stocks 34.84%11.71%53.45%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Rubric capital management lp30.05M18.02%$24.04M
Clearline capital lp12.24M7.34%$9.79M
Blackrock funding, inc. /de10.11M6.06%$8.09M
Orbimed advisors9.82M5.89%$7.85M
Vanguard group9.82M5.76%$12.77M
Blackrock8.33M5.51%$29.14M
Velan capital investment management lp8.75M5.25%$7.00M
Millennium management7.63M4.58%$6.11M
Tejara capital6.34M3.80%$5.07M
Tang capital management6.25M3.75%$5.00M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Velan capital investment management lp8.75M4.39%$7.00M
Tejara capital6.34M1.67%$5.07M
Jw asset management3.75M1.23%$3.00M
Congress park capital4.03M0.99%$3.23M
Richmond brothers1.44M0.77%$1.15M
Cm management1.00M0.67%$800.10K
Orchard capital management680.43K0.57%$544.41K
Clearline capital lp12.24M0.51%$9.79M
Stonepine capital management1.40M0.45%$1.12M
Rubric capital management lp30.05M0.25%$24.04M

Top Buyers

HolderShares% AssetsChange
Orbimed advisors9.82M0.16%9.82M
Baker bros. advisors lp4.25M0.04%4.25M
Vanguard group9.82M0.00%1.36M
Pale fire capital se2.72M0.19%1.25M
Tejara capital6.34M1.67%1.21M

Top Sellers

HolderShares% AssetsChange
Adage capital partners gp---11.19M
Point72 asset management---4.78M
Aigh capital management---3.01M
Jane street group---1.37M
Citadel advisors759.27K0.00%-1.34M

New Positions

HolderShares% AssetsChangeValue
Orbimed advisors9.82M0.16%9.82M$7.85M
Baker bros. advisors lp4.25M0.04%4.25M$5.36M
Vanguard fiduciary trust1.15M0.00%1.15M$922.17K
Acadian asset management513.17K0.00%513.17K$409.00K
Universal- beteiligungs- und servicegesellschaft mbh458.77K0.00%458.77K$367.06K

Sold Out

HolderChange
Allspring global investments-1.00
Sarver vrooman wealth advisors-1.00
Toronto dominion bank-9.00
Lindbrook capital-16.00
Mid-american wealth advisory group-24.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2026167-4.02%156,599,4410.08%931.11%78-4.88%43-2.27%
Dec 31, 202586-50.86%47,611,662-68.81%270.28%36-54.43%18-63.27%
Sep 30, 202590-45.78%46,256,389-62.08%300.48%31-63.10%27-18.18%
Jun 30, 20251742.35%131,460,8435.36%851.29%8714.47%34-26.09%
Mar 31, 20257-95.81%36,006,112-68.67%230.41%4-94.12%--100.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF4.68M3.07%-
Vanguard Total Stock Mkt Idx Inv5.47M2.90%-
Palisade Small Cap Core Equity4.42M2.34%59.93K
iShares Russell 2000 ETF3.72M1.97%31.35K
Franklin US Small Cap Growth Equity1.80M1.19%-
Vanguard Institutional Extnd Mkt Idx Tr2.03M1.08%-
Fidelity Small Cap Index1.48M0.79%-6.01K
Biotech Growth Ord1.26M0.67%1.26M
iShares Russell 2000 Value ETF1.14M0.60%6.13K
State St Russell Sm/Mid Cp® Indx NL Cl C851.80K0.56%3.84K

Recent Insider Transactions


DateNameRoleActivityValue
Aug 08, 2025Rubric Capital Management LP-Buy$3.58M
Aug 08, 2025Rubric Capital Management LP-Buy-
Aug 08, 2025Rubric Capital Management LP-Buy-
Aug 08, 2025Morgan Adam-Buy$105.02K
Aug 08, 2025Morgan Adam-Buy$2.65M

Insider Transactions Trends


DateBuySell
2026 Q2--
2026 Q1--
2025 Q4--
2025 Q35-
2025 Q2--

HRTX Ownership FAQ


Who Owns Heron Therapeutics?

Heron Therapeutics shareholders are primarily institutional investors at 93.94%, followed by 0.88% insiders and 5.18% retail investors. The average institutional ownership in Heron Therapeutics's industry, Biotech Stocks , is 34.84%, which Heron Therapeutics exceeds.

Who owns the most shares of Heron Therapeutics?

Heron Therapeutics’s largest shareholders are Rubric capital management lp (30.05M shares, 18.02%), Clearline capital lp (12.24M shares, 7.34%), and Blackrock funding, inc. /de (10.11M shares, 6.06%). Together, they hold 31.43% of Heron Therapeutics’s total shares outstanding.

Does Blackrock own Heron Therapeutics?

Yes, BlackRock owns 5.51% of Heron Therapeutics, totaling 8.33M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 29.14M$. In the last quarter, BlackRock increased its holdings by 1.04M shares, a 14.27% change.

Who is Heron Therapeutics’s biggest shareholder by percentage of total assets invested?

Velan capital investment management lp is Heron Therapeutics’s biggest shareholder by percentage of total assets invested, with 4.39% of its assets in 8.75M Heron Therapeutics shares, valued at 7M$.

Who is the top mutual fund holder of Heron Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Heron Therapeutics shares, with 3.07% of its total shares outstanding invested in 4.68M Heron Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools